Metabolism-focused CRISPR screen unveils Mitochondrial Pyruvate Carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
Takashi Furusawa(National Institutes of Health), Urbain Weyemi(National Institutes of Health)
Cited by 0
Related Papers
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence
|Oncogene|2011|282
The histone variant H2A.X is a regulator of the epithelial–mesenchymal transition
|Nature Communications|2016|81
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
|Molecular Carcinogenesis|2024|5
CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2
Histone H2AX Promotes Metastatic Progression by Preserving Glycolysis via Hexokinase-2
|Research Square|2021|1